V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195041 | 20124772 | 1.7 | 71.8 | null | 2018-07-09 | 2018-07-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100366790 |
| 20195048 | 20124773 | 1.63 | 81 | Palliative (P) | 2017-08-03 | 2017-08-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101808809 |
| 20195052 | 20124774 | 1.68 | 74.7 | null | 2019-11-02 | 2019-11-18 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101532982 |
| 20195053 | 20124775 | 1.74 | 71.4 | null | 2017-05-17 | 2017-05-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100329986 |
| 20195054 | 20124776 | 1.78 | 78 | Palliative (P) | 2019-12-16 | 2019-12-19 | Docetaxel | 02 | N | DOCETAXEL | 100038536 |
| 20195061 | 20124777 | 1.81 | 79.7 | Neo-adjuvant (N) | 2016-11-23 | 2018-10-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101517212 |
| 20195063 | 20124778 | 1.52 | 87.2 | 03 | 2017-01-21 | 2017-02-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100783169 |
| 20195065 | 20124779 | 1.76 | 66 | Palliative (P) | 2020-02-22 | 2020-03-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100019713 |
| 20195067 | 20124780 | 1.69 | 83.7 | null | 2018-10-22 | 2018-10-22 | CAPECITABINE + GEMCITABINE | null | null | CAPECITABINE + GEMCITABINE | 100209097 |
| 20195069 | 20124781 | 1.63 | 70 | Palliative (P) | 2019-12-12 | 2019-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101311399 |
| 20195071 | 20124782 | 1.68 | 73 | Palliative (P) | 2019-12-08 | 2019-12-09 | Docetaxel | 02 | N | DOCETAXEL | 100723244 |
| 20195072 | 20124783 | 1.83 | 47 | Palliative (P) | 2020-03-04 | 2020-03-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100163812 |
| 20195074 | 20124784 | 1.55 | 46.4 | null | 2019-09-17 | 2019-09-17 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 101368099 |
| 20195082 | 20124785 | 1.91 | 74.15 | Palliative (P) | 2020-07-29 | 2020-08-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 101819017 |
| 20195085 | 20124786 | 1.87 | 69.8 | Palliative (P) | null | 2019-05-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101406283 |
| 20195089 | 20124787 | 1.9 | 101 | Adjuvant (A) | 2017-03-08 | 2017-03-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101735188 |
| 20195090 | 20124788 | 1.63 | 72.05 | Palliative (P) | 2017-02-15 | 2017-03-01 | Docetaxel | 02 | N | DOCETAXEL | 101022150 |
| 20195092 | 20124789 | 1.76 | 106.4 | Palliative (P) | 2020-06-24 | 2020-07-06 | Docetaxel | 02 | N | DOCETAXEL | 100376884 |
| 20195095 | 20124790 | 1.82 | 70.9 | Palliative (P) | 2017-05-02 | 2017-05-07 | Docetaxel | 02 | N | DOCETAXEL | 101154339 |
| 20195101 | 20124791 | 1.58 | 64 | null | 2019-03-08 | 2019-03-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100639655 |
| 20195102 | 20124792 | 1.7 | 77.65 | Palliative (P) | 2018-03-27 | 2018-03-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101264500 |
| 20195110 | 20124793 | 1.63 | 57.6 | null | 2018-04-03 | 2018-04-10 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100776215 |
| 20195111 | 20124794 | 1.66 | 101 | Palliative (P) | 2017-03-19 | 2017-04-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101391939 |
| 20195113 | 20124795 | 1.69 | 68.1 | Palliative (P) | 2016-07-29 | 2016-07-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100887555 |
| 20195127 | 20124796 | 1.74 | 51 | Palliative (P) | 2019-06-30 | 2019-07-02 | Docetaxel | 02 | N | DOCETAXEL | 100337188 |
| 20195130 | 20124797 | 1.7 | 83 | null | 2017-03-14 | 2017-03-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101001263 |
| 20195133 | 20124798 | 1.54 | 53.5 | null | 2017-03-13 | 2017-03-14 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101294976 |
| 20195137 | 20124799 | 1.59 | 56 | Palliative (P) | 2018-10-14 | 2018-11-01 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100044938 |
| 20195142 | 20124800 | 1.63 | 81.4 | null | 2019-12-19 | 2020-03-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100654505 |
| 20195144 | 20124801 | 1.85 | 58.2 | Palliative (P) | 2017-05-31 | 2017-05-31 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 100559268 |
| 20195145 | 20124802 | 1.76 | 83 | Palliative (P) | 2017-10-21 | 2017-12-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100528602 |
| 20195147 | 20124803 | 1.61 | 57 | Palliative (P) | 2016-12-15 | 2017-01-03 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100739876 |
| 20195149 | 20124804 | 1.74 | 51.8 | Palliative (P) | 2017-01-02 | 2017-01-04 | Docetaxel | 02 | N | DOCETAXEL | 100101132 |
| 20195161 | 20124805 | 1.66 | 51.6 | Palliative (P) | 2017-10-25 | 2017-11-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100850620 |
| 20195163 | 20124806 | 1.63 | 63.5 | null | 2018-09-11 | 2019-02-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101762611 |
| 20195164 | 20124807 | 1.7 | 66.4 | Palliative (P) | 2017-08-21 | 2017-08-21 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100736038 |
| 20195167 | 20124808 | 2 | 91.9 | Palliative (P) | 2018-09-25 | 2018-09-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100655080 |
| 20195170 | 20124809 | null | 98 | Palliative (P) | 2017-07-15 | 2017-08-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100056897 |
| 20195171 | 20124810 | 1.81 | 35.8 | Palliative (P) | 2016-06-07 | 2016-06-17 | CETUXIMAB + IRINOTECAN + MDG | N | N | CAPECITABINE + GEMCITABINE | 101851016 |
| 20195174 | 20124811 | 1.75 | 103.8 | Palliative (P) | 2019-01-20 | 2019-01-21 | Docetaxel | 02 | null | DOCETAXEL | 101022769 |
| 20195175 | 20124812 | 1.81 | 109.35 | Palliative (P) | 2021-11-30 | 2021-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100839593 |
| 20195183 | 20124813 | 1.76 | 73.9 | Adjuvant (A) | 2018-11-21 | 2018-11-28 | Docetaxel | 02 | N | DOCETAXEL | 100089587 |
| 20195186 | 20124814 | 1.6 | 54.15 | Palliative (P) | 2015-11-22 | 2016-06-05 | Gemcitabine + Capecitabine | null | null | CAPECITABINE + GEMCITABINE | 101744552 |
| 20195189 | 20124815 | 1.7 | 53 | Palliative (P) | 2018-05-23 | 2018-06-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101291017 |
| 20195194 | 20124816 | 1.49 | 64 | Palliative (P) | 2017-10-28 | 2017-11-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100322067 |
| 20195201 | 20124817 | null | 101 | Adjuvant (A) | 2016-10-04 | 2016-10-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100072311 |
| 20195206 | 20124818 | 1.76 | 52 | null | 2016-12-31 | 2017-01-06 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100522495 |
| 20195208 | 20124819 | 1.86 | 49.5 | Neo-adjuvant (N) | 2018-07-20 | 2018-09-20 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 101528235 |
| 20195210 | 20124820 | 1.67 | 62.85 | Palliative (P) | 2019-06-06 | 2019-06-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101394346 |
| 20195211 | 20124821 | 1.79 | 62.2 | Palliative (P) | 2017-07-20 | 2018-10-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100134615 |